Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)
NCT ID: NCT00768443
Last Updated: 2010-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2674 participants
OBSERVATIONAL
2008-09-30
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects with a diagnosis of GERD and with predominant typical GERD symptoms: heartburn/regurgitation
* Subjects who fail to obtain satisfactory symptomatic response after their first full course (4-8 weeks) of standard dose PPI (once a day)
Exclusion Criteria
* Subjects where the only reason for the visit is renewing the prescription
* A history of an incomplete response to PPI treatment prior to current course of treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Bjelovar, , Croatia
Research Site
Bulinec, , Croatia
Research Site
Crikvenica, , Croatia
Research Site
Daruvar, , Croatia
Research Site
Delnice, , Croatia
Research Site
Garešnica, , Croatia
Research Site
Gospić, , Croatia
Research Site
Ivanec, , Croatia
Research Site
Kalnik, , Croatia
Research Site
Karlovac, , Croatia
Research Site
Konjšćina, , Croatia
Research Site
Koprivnica, , Croatia
Research Site
Krapina, , Croatia
Research Site
Lovran, , Croatia
Research Site
Ludbreg, , Croatia
Research Site
Nedelišće, , Croatia
Research Site
Opatija, , Croatia
Research Site
OriovacGornja Vrba, , Croatia
Research Site
OtokPrivlakaIlokVukovarRetkovciGunjGarcin, , Croatia
Research Site
Pregrada, , Croatia
Research Site
PulaPorecPazinLabinRovinj, , Croatia
Research Site
Rijeka, , Croatia
Research Site
Samobor, , Croatia
Research Site
SenjVodiceTrogirSinjImotskiMokosicaPloceMetkovic, , Croatia
Research Site
Sisak, , Croatia
Research Site
SlavonskibrodOsijekVisnjevacKoskaDonji miholjacPleternicaVelik, , Croatia
Research Site
VarazdinCakovec, , Croatia
Research Site
Virje, , Croatia
Research Site
Zabok, , Croatia
Research Site
ZadarSibenikDubrovnik, , Croatia
Research Site
Zagreb, , Croatia
Research Site
Zlatar, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-GHR-NEX-2008/1
Identifier Type: -
Identifier Source: org_study_id